zum Originalbeitrag

Das ist wohl der Grund für den heutigen Anstieg:

Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001. VLA2001 is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe.

  

Beitrag dem Admin melden | Urheberrechtsverletzung melden

Thema #8487
 Erstes Thema | Letztes Thema


Powered by DCForum+ Version 1.27
Copyright 1997-2003 DCScripts.com
0.07